PDF, A4 - 16 pages

Protect Information Assets, Enable Defensible Disposition, and Harmonize Records Management

Excerpt:
Pharmaceutical companies face far more regulations and laws than most others, and are forced to embrace stricter governance controls to effectively operate and compete on a global scale. These challenges are enhanced by many factors including merger and acquisition activities, and the increasing complexity of the drug discovery and development process.
These multifaceted challenges are becoming more complex with growing clinical trial disclosure and global submissions requirements.
To comply with these demands, ...